Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Circ J ; 82(3): 847-856, 2018 02 23.
Artigo em Inglês | MEDLINE | ID: mdl-29187666

RESUMO

BACKGROUND: Peripheral artery disease (PAD) is an athero-occlusive disease and a known risk factor for cardiovascular events. The controlling nutritional status (CONUT) score and geriatric nutritional risk index (GNRI) are objective tools for evaluating malnutrition and are reportedly associated with poor clinical outcomes in patients with fatal diseases. However, the effect of malnutrition on the clinical outcomes in patients with PAD remains unclear.Methods and Results:We enrolled 357 patients with PAD who underwent endovascular therapy. Malnutrition was diagnosed by CONUT score and GNRI as in previous reports. During a median follow-up period of 1,071 days, there were 67 major adverse cardiovascular and leg events (MACLEs). The CONUT score- and GNRI-based malnutrition statuses were identified in 56% and 46% of the patients, respectively. Proportion of malnutrition increased with advancing Fontaine class. The multivariate Cox proportional hazard regression analysis demonstrated that both the CONUT score- and GNRI-based malnutrition status was an independent predictor of MACLEs. The Kaplan-Meier analysis demonstrated that the MACLE ratio increased with deteriorating malnutrition. Finally, the addition of the CONUT score or GNRI to the known risk factors significantly improved the net reclassification index and integrated discrimination index. CONCLUSIONS: Malnutrition was common and closely associated with the clinical outcomes in patients with PAD, indicating that it is a novel therapeutic target in the management of these patients.


Assuntos
Desnutrição/complicações , Estado Nutricional , Doença Arterial Periférica/complicações , Idoso , Idoso de 80 Anos ou mais , Doenças Cardiovasculares/etiologia , Procedimentos Endovasculares , Feminino , Humanos , Estimativa de Kaplan-Meier , Masculino , Doença Arterial Periférica/terapia , Resultado do Tratamento
2.
Pacing Clin Electrophysiol ; 41(12): 1635-1642, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30288753

RESUMO

INTRODUCTION: The predictive value of left atrial volume (LAV) in atrial fibrillation (AF) is known, but the relationship of right atrial volume (RAV) and biatrial volume (BAV) with AF recurrence after pulmonary vein isolation (PVI) is not clear. Cardiac magnetic resonance (CMR) imaging allows us to more precisely quantify atrial volume. We investigated LAV, RAV, and BAV as predictors of AF recurrence following PVI in AF patients. METHODS AND RESULTS: We assessed 100 AF patients (age = 59.8 ± 9.5 years, 74 males, 26 females) who underwent nonenhanced CMR before their first PVI. LAV and RAV were measured using CMR. All patients were in sinus rhythm during CMR. BAV was calculated as the sum of LAV and RAV. During the 8-month follow-up, AF recurrence occurred in 23 patients. LAV, RAV, and BAV were significantly greater in patients with AF recurrence than in those without (LAV, 103.7 ± 25.8 vs 81.8 ± 24.2 mL, P < 0.001; RAV, 109.4 ± 27.0 vs 82.2 ± 19.6 mL, P < 0.001; BAV, 213.1 ± 46.7 vs 164.1 ± 38.7 mL, P < 0.001). Multivariate logistic regression analysis revealed that increased LAV, RAV, and BAV were significantly correlated with AF recurrence. The area under the receiver operation characteristic curve for BAV showed the largest value compared to that of LAV or RAV alone. CONCLUSIONS: LAV, RAV, and BAV were independent predictors of AF recurrence after PVI. Quantifying BAV may additionally improve prognostic stratification compared with LAV or RAV.


Assuntos
Fibrilação Atrial/cirurgia , Ablação por Cateter/métodos , Imageamento por Ressonância Magnética/métodos , Fibrilação Atrial/fisiopatologia , Ecocardiografia , Mapeamento Epicárdico , Feminino , Humanos , Interpretação de Imagem Assistida por Computador , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Recidiva , Resultado do Tratamento
3.
Clin Cardiol ; 27(4): 204-10, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15119694

RESUMO

BACKGROUND: Heart failure is a major and growing public health problem with a high mortality rate. Although recent studies have demonstrated that a variety of metabolic and/or neurohumoral factors are involved in the progression of this syndrome, the precise mechanisms responsible for this complex condition are poorly understood. HYPOTHESIS: To examine 123I-beta-methyl-iodophenylpentadecanoic acid (BMIPP) kinetics in the early phase soon after tracer injection in patients with congestive heart failure (CHF), we performed dynamic single-photon emission computed tomography (SPECT). METHODS: Twenty-six patients with CHF and eight control subjects were examined. The consecutive 15 images of 2-min dynamic SPECT were acquired for 30 min after injection. In the early phase after injection (0-4 min), a significant amount of radioactivity existed in the blood pool. After 6 min, the myocardial 123I-BMIPP image was clear and thus the washout rate of 123I-BMIPP from 6 to 30 min was calculated. RESULTS: The washout rate of 123I-BMIPP from the myocardium was faster in patients with CHF than in the controls (8 +/- 4 vs. -5 +/- 3%, p < 0.01). The washout rate of 123I-BMIPP demonstrated positive correlation with left ventricular (LV) end-diastolic volume index (R = 0.54, p < 0.02) and inverse correlation with LV ejection fraction (R = 0.53, p <0.02). Patients were given the angiotensin II type-1 receptor antagonist candesartan for 6 months, and dynamic SPECT was repeated. The enhanced washout rate of 123I-BMIPP in CHF was reduced after treatment with candesartan (p < 0.05). CONCLUSION: These data suggest that (1) enhanced washout of 123I-BMIPP was observed soon after injection in patients with CHF, (2) the activation of angiotensin II signaling pathway is involved as an intracellular mechanism for enhanced 123I-BMIPP washout in heart failure, and (3) improvement in fatty acid metabolism may represent a new mechanism for beneficial effects of angiotensin II receptor blockade on cardiac function and survival in patients with heart failure. 123I-BMIPP washout in the early phase obtained from dynamic SPECT may be a new marker for evaluating the severity of heart failure and the effects of medical treatment.


Assuntos
Bloqueadores do Receptor Tipo 1 de Angiotensina II , Insuficiência Cardíaca/diagnóstico por imagem , Tomografia Computadorizada de Emissão de Fóton Único , Adulto , Idoso , Idoso de 80 Anos ou mais , Angiotensina II/antagonistas & inibidores , Angiotensina II/metabolismo , Estudos de Casos e Controles , Ácidos Graxos/metabolismo , Feminino , Humanos , Radioisótopos do Iodo/farmacocinética , Iodobenzenos , Masculino , Pessoa de Meia-Idade , Receptor Tipo 1 de Angiotensina/metabolismo , Fatores de Tempo , Tomografia Computadorizada de Emissão de Fóton Único/métodos
4.
Am J Physiol Heart Circ Physiol ; 282(1): H212-8, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11748065

RESUMO

The mechanism of arrhythmogenicity in heart failure remains poorly understood. We examined the relationship between electrical abnormalities and ventricular arrhythmia by using experimental heart failure models. Sixty unipolar electrograms were recorded from the entire cardiac surface in control dogs (n = 13) and pacing-induced heart failure dogs (n = 16). In failing hearts, activation time (AT) was delayed at the apex, and AT dispersion increased in failing hearts. Activation-recovery intervals (ARI) were prolonged mainly at the apex and ARI dispersion was significantly augmented. The slope of the ARI restitution curve, interaction of diastolic interval, and ARI in failing hearts was significantly steeper than in control hearts. Ventricular fibrillation (VF) was easily induced by programmed stimulation in failing hearts, whereas no arrhythmia occurred in control hearts. Computer simulation studies could reproduce the experimental results. Altering the ARI restitution to the steep slope causes VF in a model heart. It is suggested that electrical remodeling, especially steepness of electrical restitution, may play a role in arrhythmogenicity in failing hearts.


Assuntos
Arritmias Cardíacas/fisiopatologia , Insuficiência Cardíaca/fisiopatologia , Hemodinâmica/fisiologia , Fibrilação Ventricular/fisiopatologia , Animais , Velocidade do Fluxo Sanguíneo , Cães , Eletrocardiografia , Ventrículos do Coração , Valores de Referência , Fatores de Tempo
5.
J Cardiovasc Electrophysiol ; 13(9): 910-4, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12380931

RESUMO

INTRODUCTION: The aim of this study was to clarify the ventricular tachyarrhythmia mechanism induced by the I(Kr)-blocking agent E4031, simulating the LQT2 form. Electrophysiologic properties were examined in 13 canines before and after administration of E4031. METHOD AND RESULTS: Thirty-six needle electrodes were inserted into the anterior left ventricular wall. From each needle, local unipolar electrograms were obtained from four intramural sites. Activation time (AT) and activation-recovery interval (ARI) were measured. To evaluate the susceptibility to ventricular arrhythmia, intramural ARI dispersions and the restitution relationship between ARI and diastolic interval were calculated. After E4031 administration, ARI prolonged uniformly in each myocardial layer. However, ARI dispersion was not augmented compared with control. The slope of the ARI restitution curve after E4031 was significantly steeper than control. A steep slope may result from augmented ARI alternans. In 11 of the 13 canines, ventricular tachyarrhythmia was induced by programmed stimulation after E4031, whereas no arrhythmia was induced by the same protocol in control. CONCLUSION: Steepness of electrical restitution may play a major role in arrhythmogenicity in LQT2 hearts.


Assuntos
Eletrocardiografia , Síndrome do QT Longo/diagnóstico , Taquicardia Ventricular/epidemiologia , Animais , Antiarrítmicos/administração & dosagem , Estimulação Cardíaca Artificial , Modelos Animais de Doenças , Suscetibilidade a Doenças , Cães , Técnicas Eletrofisiológicas Cardíacas , Sistema de Condução Cardíaco/efeitos dos fármacos , Sistema de Condução Cardíaco/patologia , Ventrículos do Coração/efeitos dos fármacos , Ventrículos do Coração/patologia , Síndrome do QT Longo/complicações , Síndrome do QT Longo/terapia , Modelos Cardiovasculares , Piperidinas/administração & dosagem , Piridinas/administração & dosagem , Taquicardia Ventricular/diagnóstico , Taquicardia Ventricular/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA